National AIDS Trust: Company Profile

Background

The National AIDS Trust (NAT) is a UK-based charity established in October 1987 to address the escalating concerns surrounding HIV and AIDS. Founded as a non-governmental organization by the UK's Department of Health, NAT was initially funded with £500,000 from the government, supplemented by a matching charitable donation from Robert Maxwell. Its founding chair was Michael Adler, with Margaret Jay serving as its first director. Diana, Princess of Wales, served as the charity's patron from 1991 to 1997, significantly contributing to its prominence.

NAT's mission is to stand alongside and defend the rights of everyone living with, affected by, or at risk of HIV. Its vision is a world where HIV does not impede health, dignity, and equality. The charity focuses on policy development, research, and advocacy to secure lasting change for people living with and at risk of HIV, rather than providing direct support services.

Key Strategic Focus

NAT's strategic objectives include:

• Preventing New HIV Infections: Implementing initiatives to reduce the transmission of HIV.

• Championing the Needs of Marginalized Groups: Advocating for individuals whose voices are often overlooked, such as those from minority communities.

• Protecting Rights: Ensuring the rights of people living with and at risk of HIV are upheld.

• Driving Engagement and Activism: Changing societal attitudes towards HIV through education and activism.

The charity specializes in policy development, research, and advocacy, utilizing evidence-based approaches to influence public health strategies and legislation. Its primary focus is on the UK market, addressing national HIV-related issues.

Financials and Funding

NAT is an independent charity that does not receive funding from the UK Government. Its funding sources include public donations, corporate supporters, grant-making trusts and foundations, and its own fundraising activities. As of June 30, 2025, the charity reported a turnover of £1.12 million and net assets of £518,080. The organization employs fewer than 20 staff members.

Pipeline Development

NAT does not engage in clinical trials or product development, as it is not a pharmaceutical company. Instead, its focus is on policy advocacy and research to influence HIV-related legislation and public health strategies in the UK.

Technological Platform and Innovation

NAT employs various technological platforms to support its advocacy and educational efforts, including:

• Digital Resources: Developing online educational materials and policy resources to inform and engage the public and policymakers.

• Data Analysis: Utilizing data analytics to monitor HIV trends and inform policy decisions.

• Social Media Engagement: Leveraging platforms like Twitter and Facebook to raise awareness and mobilize support.

These technological initiatives enhance NAT's ability to advocate effectively and reach a broader audience.

Leadership Team

NAT's leadership team comprises:

• Robbie Currie: Chief Executive Officer since 2024, with over 30 years in the sexual and reproductive health and HIV sector. Previously led the London HIV Prevention Programme and managed national HIV prevention programs.

• Hannah Daws: Director of Fundraising and Communications since July 2023, bringing nearly 30 years of experience in senior communications and fundraising roles across public and third sectors.

• Daniel Fluskey: Director of Policy, Research, and Influencing since October 2023, focusing on policy priorities to protect and enhance the rights of people living with HIV.

Competitor Profile

In the UK, NAT's primary competitors include:

• Terrence Higgins Trust (THT): A leading HIV and sexual health charity offering support services, advocacy, and education.

• British HIV Association (BHIVA): A professional association for HIV specialists, influencing clinical practice and policy.

• NAM (National AIDS Manual): Provides information and resources on HIV treatment and prevention.

Internationally, organizations such as amfAR, The Foundation for AIDS Research, and the AIDS Foundation of Chicago also operate in the HIV advocacy and research space.

Strategic Collaborations and Partnerships

NAT collaborates with various organizations to strengthen its impact, including:

• Terrence Higgins Trust (THT): In February 2025, NAT and THT agreed to transfer assets from NAM Publications to THT, ensuring the continuation of NAM's legacy and resources.

• Corporate Partners: NAT engages with corporate partners to support its initiatives, including fundraising events and campaigns.

Operational Insights

NAT's strategic considerations include:

• Advocacy Focus: Emphasizing policy change and public education to address HIV-related issues.

• Resource Allocation: Prioritizing funding towards research, advocacy, and educational programs.

• Partnerships: Building alliances with other organizations to enhance service delivery and influence policy.

Strategic Opportunities and Future Directions

NAT's strategic roadmap includes:

• Policy Influence: Continuing to shape HIV-related legislation and public health strategies in the UK.

• Public Engagement: Expanding outreach to diverse communities to raise awareness and reduce stigma.

• Global Collaboration: Partnering with international organizations to address global HIV challenges.

Contact Information

• Website: www.nat.org.uk

• Social Media:

• Twitter: @NAT_AIDS_Trust

• Facebook: National AIDS Trust